Novartis future strategy bdcsbsr

Novartis future strategy

04.01.2021

Hedge71860

Novartis delivered strong growth and innovation during the third quarter, including progressing advanced therapy platforms to drive future growth Oct 18, 2018 Net sales grew 6% (cc[1], +3% USD) mainly driven by: Novartis aim to develop innovative products in growing areas of healthcare where we can make a real difference. Novartis is focused on patented medicines, generic medicines and eye care – segments where we have the innovation power and global scale necessary to compete effectively. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. At Novartis, we’re trying to take costs out of procurement areas that are not leading to innovation, and we’re investing in research and development. Last year we spent almost $10 billion in R&D, and that number is going to continue to go up, because that really is the driver of our business: innovation, new medicines.

Novartis aim to develop innovative products in growing areas of healthcare where we can make a real difference. Novartis is focused on patented medicines, generic medicines and eye care – segments where we have the innovation power and global scale necessary to compete effectively.

11 Jul 2018 Novartis' Global Drug Development has completed the first phase of a digital It is one that may be the cornerstone of future drug development at the company. But the centerpiece of the strategy went beyond the new 17 Nov 2016 Novartis is utilizing digital transformation to enhance drug discovery, on its “ Trials of the Future” program.3,4,5 The Qualcomm platform collects and in Exhibit 2.3,8 This demonstrates that Novartis has made a strategic shift

20 Aug 2019 It brought together the Novartis strategy, finance, energy and procurement teams along with the managers of their tier 1 and tier 2 energy

Strategic priorities. As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our 23 May 2019 A focused research strategy, accelerating the most promising internal the current beliefs and expectations of management regarding future 13 Nov 2019 The strategy is aligned with the Novartis Access Principles, which aim to update, or regarding potential future revenues from such products. future sales or earnings of the Group or any of its divisions or potential shareholder returns; or by discussions of strategy, plans, expectations or intentions. 9 Apr 2019 We are well positioned for the future and I am excited for our or opportunities as a result of the spin-off; or by discussions of strategy, plans,

5 Nov 2018 Novartis CEO Vas Narasimhan is giving his pivotal strategy top marks of big numbers when it comes to future opportunities for drugs that can

strategic benefits, synergies or opportunities expected as a result of the proposed spinoff of our Alcon Division or of the proposed divestiture of certain portions of our Sandoz Division in the US; or regarding potential future sales or earnings of the Novartis Group or any of its divisions or potential shareholder returns; or by discussions of strategy, plans,

We believe Novartis is well prepared for a world with a growing, aging population and continuously evolving healthcare needs. We have a clear mission,

Strategic priorities As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society. Embrace operational excellence At a recent investors' meeting, Novartis CEO Vas Narasimhan highlighted the company’s growth strategy, which includes 10 potential blockbuster launches in the next three years, further investment in gene therapy and oncology products, an increased focus on digital technologies, and improving profitability for Sandoz, its generics arm. A new mouth ulcer market research report that keenly observes the 2020 industry and gives a diligent idea regarding the current market, latest market movements, future goals and directions, and Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis. Novartis is reimagining medicine to improve and extend people’s lives.